RECRUITING

Targeted EHR-based Communication of Diagnostic Uncertainty in the ED

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of the clinical trial is to evaluate the preliminary effectiveness and the implementation feasibility of the Targeted EHR-based Communication about Uncertainty (TECU) strategy in improving the quality of care transitions from the emergency department (ED) to home. The overall specific aims related to the trial are to test the preliminary effectiveness of TECU compared to standard of care in reducing patient uncertainty and return ED visits and evaluate the adoption of TECU, exploring patient and clinician barriers and facilitators to TECU implementation.

Official Title

Targeted EHR-based Communication of Diagnostic Uncertainty (TECU) in the ED: An Effectiveness Implementation Trial

Quick Facts

Study Start:2024-11-05
Study Completion:2027-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06638021

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * age 18 years or older
  2. * English language speaking
  3. * assigned a symptom-based diagnosis in the EHR clinical impression
  4. * planned for discharge from the ED during the enrollment visit
  5. * able to complete follow up assessments in 2 and 30 days
  6. * TECU best practice advisory (BPA) electronic health record alert activates during their discharge process
  1. * under the age of 18 years
  2. * non-English speaking
  3. * clinically unstable, psychologically impaired or intoxicated, or otherwise unable to provide informed consent as judged by research staff member
  4. * admitted to hospital
  5. * unable to complete follow up in 2 and 30 days
  6. * previously enrolled in this study (during a prior ED visit)

Contacts and Locations

Study Contact

Kristin L Rising, MD, MS
CONTACT
2673031359
kristin.rising@jefferson.edu
Amanda MB Doty, MS
CONTACT
2155034619
amanda.doty@jefferson.edu

Principal Investigator

Kristin L Rising, MD, MS
PRINCIPAL_INVESTIGATOR
Thomas Jefferson University

Study Locations (Sites)

Thomas Jefferson University
Philadelphia, Pennsylvania, 19107
United States

Collaborators and Investigators

Sponsor: Thomas Jefferson University

  • Kristin L Rising, MD, MS, PRINCIPAL_INVESTIGATOR, Thomas Jefferson University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-05
Study Completion Date2027-07-01

Study Record Updates

Study Start Date2024-11-05
Study Completion Date2027-07-01

Terms related to this study

Keywords Provided by Researchers

  • Patient uncertainty
  • Symptom-based diagnosis
  • ED Discharge Communication
  • Diagnostic Uncertainty
  • Best practice advisory

Additional Relevant MeSH Terms

  • Diagnostic Uncertainty